the PASTEUR Act would establish a subscription-style model which would offer antibiotic developers predictable payments in exchange for access to their antibiotics, encouraging innovation and ensuring our health care system is prepared to treat resistant infections.
Establish a subscription-style federal payment model for novel antimicrobials that gives developers predictable payments in exchange for access to critical antibiotics.
Occurrences
Evidence
unverified · Source version 61966 · locator unknown
GovInfo lists S. 4875 as introduced June 23, 2026, with Todd Young as a cosponsor, read twice and referred to the Senate HELP Committee.
legacy_unverified · Source version not recorded · locator unknown
Young's office said the PASTEUR Act would offer antibiotic developers predictable payments in exchange for access to their antibiotics, and noted prior introductions in 2020, 2021, and 2023.
Assessments
The promised subscription-style federal payment model for novel antimicrobials has not been enacted or implemented. Young materially advanced the matching proposal through the PASTEUR Act, including the 2026 reintroduction and cosponsorship, but the cited official bill status shows only introduction and referral to the Senate HELP Committee. That is a serious legislative attempt during his current Senate term, not delivery of the promised federal payment model.